NR0B2 and prostate carcinoma: SHP overexpression also suppressed cell proliferation in prostate cancer cells [16], increased apoptosis in LNCaP cells [18], and induced cell cycle arrest at G1 phase in PC-3 cells [19], suggesting SHP exerts an antioncogenic role in prostate cancer.